Abstract:Poxvirus genomes consist of a linear duplex DNA that ends in short inverted and complementary hairpin structures. These elements also encode loops and mismatches that likely serve a role in genome packaging and perhaps replication. We constructed mutant vaccinia viruses (VACV) where the native hairpins were replaced by altered forms and tested effects on replication, assembly, and virulence. Our studies showed that structure, not sequence, likely determines function as one can replace an Orthopoxvirus (VACV) h… Show more
“…Similarly, MySEV encoded a tyrosine recombinase (Figure 4C) and a primase-helicase (Figure 4D) that were closely related to those of CBEV_PLV1. While these MySEV components were encoded in separate regions of the MySEV genome, poxviruses have been hypothesized to initiate replication out of hairpin structures, referred to as telomeres, that occur within the TIRs(Shenouda et al 2022). Tyrosine recombinase activity on these ends could be a mechanism for genome dimer resolution, as occurs in bacterial genomes, plasmids, and some bacteriophages (Castillo et al 2017; Haenebalcke and Haigh 2013).…”
Polinton-like viruses (PLVs) are a diverse group of small integrative dsDNA viruses that infect diverse eukaryotic hosts. Many PLVs are hypothesized to parasitize viruses in the phylum Nucleocytoviricota for their own propagation and spread. Here we analyze the genomes of novel PLVs associated with the occlusion bodies of entomopoxvirus (EV) infections of two separate lepidopteran hosts. The presence of these elements within EV occlusion bodies suggests that they are the first known hyperparasites of poxviruses. We find that these PLVs belong to two distinct lineages that are highly diverged from known PLVs. These PLVs possess mosaic genomes, and some essential genes share homology with mobile genes within EVs. Based on this homology and observed PLV mosaicism, we propose a mechanism to explain the turnover of PLV replication and integration genes.
“…Similarly, MySEV encoded a tyrosine recombinase (Figure 4C) and a primase-helicase (Figure 4D) that were closely related to those of CBEV_PLV1. While these MySEV components were encoded in separate regions of the MySEV genome, poxviruses have been hypothesized to initiate replication out of hairpin structures, referred to as telomeres, that occur within the TIRs(Shenouda et al 2022). Tyrosine recombinase activity on these ends could be a mechanism for genome dimer resolution, as occurs in bacterial genomes, plasmids, and some bacteriophages (Castillo et al 2017; Haenebalcke and Haigh 2013).…”
Polinton-like viruses (PLVs) are a diverse group of small integrative dsDNA viruses that infect diverse eukaryotic hosts. Many PLVs are hypothesized to parasitize viruses in the phylum Nucleocytoviricota for their own propagation and spread. Here we analyze the genomes of novel PLVs associated with the occlusion bodies of entomopoxvirus (EV) infections of two separate lepidopteran hosts. The presence of these elements within EV occlusion bodies suggests that they are the first known hyperparasites of poxviruses. We find that these PLVs belong to two distinct lineages that are highly diverged from known PLVs. These PLVs possess mosaic genomes, and some essential genes share homology with mobile genes within EVs. Based on this homology and observed PLV mosaicism, we propose a mechanism to explain the turnover of PLV replication and integration genes.
“…Recombinant chimeric HPXV (rcHPXV) and vaccinia (rVACV) were utilized as vaccines. The methods for the generation of rcHPXV and rVACV have been previously described [ 19 , 23 ]. The rVACV genome sequence was deposited into GenBank (Accession # MN974381).…”
The ongoing global Monkeypox outbreak that started in the spring of 2022 has reinforced the importance of protecting the population using live virus vaccines based on the vaccinia virus (VACV). Smallpox also remains a biothreat and although some U.S. military personnel are immunized with VACV, safety concerns limit its use in other vulnerable groups. Consequently, there is a need for an effective and safer, single dose, live replicating vaccine against both viruses. One potential approach is to use the horsepox virus (HPXV) as a vaccine. Contemporary VACV shares a common ancestor with HPXV, which from the time of Edward Jenner and through the 19th century, was extensively used to vaccinate against smallpox. However, it is unknown if early HPXV-based vaccines exhibited different safety and efficacy profiles compared to modern VACV. A deeper understanding of HPXV as a vaccine platform may allow the construction of safer and more effective vaccines against the poxvirus family. In a proof-of-concept study, we vaccinated cynomolgus macaques with TNX-801, a recombinant chimeric horsepox virus (rcHPXV), and showed that the vaccine elicited protective immune responses against a lethal challenge with monkeypox virus (MPXV), strain Zaire. The vaccine was well tolerated and protected animals from the development of lesions and severe disease. These encouraging data support the further development of TNX-801.
“…Finally, reactivation reactions have also been used to reconstruct and reactivate poxviruses using DNA fragments obtained through wholly synthetic approaches. The first such example was a 220 kbp horsepox virus [204], but synthetic copies of VACV strains MVA [205], and Acambis 2000 [206], have since also been constructed in similar ways. An advantage of these methods is the flexibility that gene synthesis offers, and as the cost of gene synthesis continues to decline [207], and interest in more complex and personalized recombinants grows, may displace many of the methods devised to date.…”
Section: Applications and Implicationsmentioning
confidence: 99%
“…An advantage of these methods is the flexibility that gene synthesis offers, and as the cost of gene synthesis continues to decline [207], and interest in more complex and personalized recombinants grows, may displace many of the methods devised to date. It makes possible the construction of mutants that would be difficult to produce in any other way [206]. Of course, the technology is not without controversy.…”
Genetic recombination is used as a tool for modifying the composition of poxvirus genomes in both discovery and applied research. This review documents the history behind the development of these tools as well as what has been learned about the processes that catalyze virus recombination and the links between it and DNA replication and repair. The study of poxvirus recombination extends back to the 1930s with the discovery that one virus can reactivate another by a process later shown to generate recombinants. In the years that followed it was shown that recombinants can be produced in virus-by-virus crosses within a genus (e.g., variola-by-rabbitpox) and efforts were made to produce recombination-based genetic maps with modest success. The marker rescue mapping method proved more useful and led to methods for making genetically engineered viruses. Many further insights into the mechanism of recombination have been provided by transfection studies which have shown that this is a high-frequency process associated with hybrid DNA formation and inextricably linked to replication. The links reflect the fact that poxvirus DNA polymerases, specifically the vaccinia virus E9 enzyme, can catalyze strand transfer in in vivo and in vitro reactions dependent on the 3′-to-5′ proofreading exonuclease and enhanced by the I3 replicative single-strand DNA binding protein. These reactions have shaped the composition of virus genomes and are modulated by constraints imposed on virus–virus interactions by viral replication in cytoplasmic factories. As recombination reactions are used for replication fork assembly and repair in many biological systems, further study of these reactions may provide new insights into still poorly understood features of poxvirus DNA replication.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.